MediSwipe now plans to create a new distribution division for its exclusive license to sell the popular hemp based energy drink "CHILLO" and hemp ice tea C+SWISS to all medical dispensaries in 19 states and the District of Columbia. "We have received an overwhelming response from both products just from what has already been placed out there. We expect to have a complete grass roots campaign in place by the end of the month in multiple cities. With the dramatic orange color and flavor of CHILLO, and added benefits of hemp, vitamins and caffeine, we have an exciting brand," stated B. Michael Friedman for MediSwipe
C+SWISS is popularly known as the original hemp based ice tea approved for sale in the United States, with distribution already in Whole Foods and major markets nationally. The hemp based drink comes in eco-friendly, recyclable packaging that stands out to the health conscious target customer. C+SWISS contains all natural ingredients including non-gmo beet sugar, concentrated lemon juice, hemp seed extract, black tea extract, and natural flavoring consisting of fruit and plant extracts.
CHILLO, with its distinct trademark orange can, carries the chill of hemp seed extract with the added punch and perfect blend of caffeine, vitamins B6 and B12 for the ultimate drink experience. Both brands will be available in dispensaries across the country starting next week, and may be ordered for dispensaries exclusively through MediSwipe by calling 248.262.6850 or through email at info@MediSwipe.com.
About MediSwipe Inc.
MediSwipe Inc. (www.MediSwipe.com) provides innovative patient solutions for electronically processing transactions within the healthcare industry. MediSwipe provides terminal-based service packages and integrated Web Portal add-ons for physicians, clinics, hospitals and medical dispensaries that include: digital patient records, Electronic Referrals, Credit/Debit Card merchant services, Check Guarantee and Accounts Receivable Financing.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of MediSwipe Inc. to be materially different from the statements made herein.
MediSwipe Inc. 248.262.6850 www.MediSwipe.com